StockData
Maze Therapeutics, Inc. logo

Maze Therapeutics, Inc. (MAZE) stock

MAZENasdaqBiological Products, (No Diagnostic Substances)Fiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 9, 2026Score 4/30
$32.87−1.03 (-3.04%)

Close on Nov 17, 2026Market cap $1.83BP/E –Yield –

Maze Therapeutics market cap

Market capitalization is the share price multiplied by the number of shares outstanding.

Maze Therapeutics's market cap was $2.04B on Nov 11, 2026, against $1.81B a year earlier.

Market Cap at the end of each year

PeriodPeriod endValueChange
2026Nov 11, 2026$2.04B+2.4%
2025Dec 31, 2025$1.99B–

More Maze Therapeutics figures

See a number that looks wrong?